Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.

Hou, Feng-Qin

Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon. [electronic resource] - Theranostics 2015 - 218-26 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1838-7640

10.7150/thno.10636 doi


Adult
Biomarkers--blood
DNA, Viral--blood
Drug Monitoring--methods
Female
Hepatitis B Antibodies--blood
Hepatitis B Core Antigens--immunology
Hepatitis B e Antigens--blood
Hepatitis B, Chronic--diagnosis
Humans
Interferon-alpha--therapeutic use
Male
Middle Aged
Predictive Value of Tests
Prognosis
Viral Load
Young Adult